SLC5A2 and heart failure: In the setting of heart failure with reduced ejection fraction, guideline-directed medical therapy is indicated with a focus on the 4 pillars of β-blockers, angiotensin receptor/neprilysin inhibitors, mineralocorticoid receptor antagonists and SGLT2 inhibitors [90].